Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer (2022)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.xcrm.2022.100781
PubMed Identifier: 36240755
Publication URI: http://europepmc.org/abstract/MED/36240755
Type: Journal Article/Review
Parent Publication: Cell Reports Medicine
Issue: 10